CCEL Short Volume
Cryo-Cell International, Inc. (CCEL) operates in the Healthcare sector, specifically the Medical - Care Facilities industry, with a market capitalization near $27.0M, listed on AMEX, employing roughly 82 people, carrying a beta of 0.58 to the broader market. Cryo-Cell International, Inc. Led by David I. Portnoy, public since 1994-04-04.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 554
- Total Volume
- 1.6K
- Short %
- 35.26%
- 30-Day Avg Short %
- 36.75%
Showing 30 days of FINRA short volume data for Cryo-Cell International, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked CCEL short volume questions
- What is the daily CCEL short volume?
- As of Jun 1, 2026, Cryo-Cell International, Inc. (CCEL) short volume is 554 shares against 1.6K total reported volume, or 35.26% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is CCEL short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does CCEL short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.